<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00588718</url>
  </required_header>
  <id_info>
    <org_study_id>26128</org_study_id>
    <nct_id>NCT00588718</nct_id>
  </id_info>
  <brief_title>A Biologic Validation of Biomarkers of Progressive NEC &amp; Sepsis</brief_title>
  <acronym>NEC</acronym>
  <official_title>A Biologic Sample Study for the Validation of Biomarkers of Progressive NEC &amp; Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>R. Lawrence Moss</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mallinckrodt</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Necrotizing enterocolitis (NEC) is a severe, sometimes life-threatening inflammation of the
      intestine that occurs most often in premature babies. If it progresses, the wall of the
      intestine may perforate, spilling bacteria and stool into the abdomen. Parts or all of the
      intestine may die. Despite 30 years of clinical studies, the cause of NEC remains unknown.

      In this study, we will be conducting an independent case-control validation study to verify
      the diagnostic and prognostic biomarker panels, develop validated biomarkers on boisensors in
      preparation for prospective validation studies, and conduct independent prospective
      validation of biosensor based biomarker panels on clinical samples.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 2007</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To verify the diagnostic and prognostic biomarker panels with sufficiently powered new cohorts.</measure>
    <time_frame>4 years</time_frame>
    <description>Study has been amended/extended. Test the NEC diagnostic panel for its ability to distinguish NEC from SIP. Develop validated biomarkers on biosensors in preparation for prospective validation studies.
Independent prospective validation of biosensor based biomarker panels.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">740</enrollment>
  <condition>Necrotizing Enterocolitis</condition>
  <arm_group>
    <arm_group_label>Cases</arm_group_label>
    <description>Infants who meet the entry criteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Banked blood samples from newborns who do not meet inclusion criteria for this study will be held at Stanford University Core Laboratory and will constitute controls. Proteomic and genomic profiles in blood samples of cases will be compared with blood samples of controls.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and Urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Prematurely-born infants with with suspected necrotizing enterocolitis, sepsis or SIP who
        meet study entry criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria - NEC/Sepsis Cohort GA &lt; 29 weeks Current age equal or &lt;12 weeks
        Suspicion of NEC or Sepsis

        Exclusion - NEC/Sepsis Cohort Current or prior diagnosis of NEC Early onset infection
        (equal or &lt;72 hours of life) Previous diagnosis of sepsis within 7 days Previous abdominal
        surgery Significant congenital anomaly

        Inclusion Criteria - SIP Cohort Infants born at &lt;29 weeks gestation Equal to or &lt;12 weeks
        of age at the time of eligibility assessment a decision to perform surgery (or drain) for
        suspected NEC or SIP

        Exclusion - SIP Cohort Congenital infection (Equal to &lt;72 hours of life) Prior episode of
        NEC or SIP Prior laparotomy or drain for SIP or NEC
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>R. Lawrence Moss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nationwide Children's Hospital, The Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>R. Lawrence Moss, MD, Nationwide Children's Hospital, The Ohio State University, Karl Sylvester, MD, Stanford University, Stanford, Califorinia</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Moss RL, Kalish LA, Duggan C, Johnston P, Brandt ML, Dunn JC, Ehrenkranz RA, Jaksic T, Nobuhara K, Simpson BJ, McCarthy MC, Sylvester KG. Clinical parameters do not adequately predict outcome in necrotizing enterocolitis: a multi-institutional study. J Perinatol. 2008 Oct;28(10):665-74. doi: 10.1038/jp.2008.119. Epub 2008 Sep 11.</citation>
    <PMID>18784730</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2008</study_first_submitted>
  <study_first_submitted_qc>January 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2008</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>R. Lawrence Moss</investigator_full_name>
    <investigator_title>Surgeon In Chief</investigator_title>
  </responsible_party>
  <keyword>Necrotizing enterocolitis</keyword>
  <keyword>Progressive necrotizing enterocolitis</keyword>
  <keyword>Proteomics in blood</keyword>
  <keyword>Genomics in blood</keyword>
  <keyword>Multi-center</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

